The Drug Discovery Cluster aims to participate in all
the stages of early phase drug discovery from chemical biology approaches to
new target identification and validation through to the nomination of quality
clinical drug candidates to treat human disease of high unmet medical need
(e.g. cancer, anti-infectives, neurosciences).
Our work is interdisciplinary, ranging from medicinal and synthetic chemistry to pharmacology, structural biology, proteomics, microbiology and phytomedicines.
The Drug Discovery Cluster is closely aligned with the UCL Translational Research Office which aims to facilitate the translation of basic and clinical research at UCL into therapies, techniques and medical products with therapeutic value.